MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
ALIM
Stock ticker:
PRICE
CHANGE
CAPITALIZATION

Alimera Sciences (ALIM) Ownership - Who owns Alimera Sciences?

Alimera Sciences Inc is a commercial-stage pharmaceutical company developing and commercializing ILUVIEN for the treatment of diabetic macular edema (DME), a cause of blindness, and outside the U... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
6310 Town Square
Phone
+1 678 990-5740
Employees
159
Web
https://www.alimerasciences.com

Details

Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
204.18M
P/E Ratio
15.80
Total Cash
12.06M
Projected Growth
N/A
Total Debt
65.32M
Revenue
80.75M
Risk (Beta)
0.74
Dividend Yield
N/A
Total Cash/Share
0.23
Total Debt/Equity
41.83
Revenue/Share
3.16 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for ALIM
A.I. Advisor
published General Information

General Information

a developer of ophthalmic pharmaceuticals

Industry PharmaceuticalsOther

Profile
Details
Industry
Biotechnology
Address
6310 Town Square
Phone
+1 678 990-5740
Employees
159
Web
https://www.alimerasciences.com